FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2022
Back to search
Official data from USPTO
TREAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TREAT
ST13
US500000079290962Class
1, 5, 9, 10, 42, 44
Filing
79290962
Registration
6661741
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/29/2022
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
05/29/2020
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
CH
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ichnos Sciences SA
Representatives
Jeffrey H. Greger Hauptman Ham, LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products used in industry and science as well as in agriculturehorticulture and forestryparticularly laboratory chemicalsbiochemicals in the nature of antibodiestrimeric antibodies and derivatives thereofall for use in the development or manufacture of immunological reagents for industrial and scientific use; laboratory chemicalsbiochemicals in the nature of antibodiestrimeric antibodies and derivatives thereof for laboratoriesdiagnostics and analytics for scientific or research use; chemical preparations for industrial and scientific use
Class 5
Medical preparationsantibodiestrimeric antibodies and derivatives thereoffor the treatment of cancerallergiesasthmaautoimmune diseasesinflammationgraft versus host diseasesinflammationtransplant rejectioninfectious diseasesbone diseasesheart diseasesendocrine diseaseseye diseasesintestinal diseases and neurological diseasesin the form of parenteralintravitrealintra-peritoneal and aerosol therapies; medical preparationsantibodies for diagnostic or therapeutic use and for use in assay
Class 9
Scientificweighingmeasuringcheckingsupervision and teaching apparatus and instruments for scientific laboratory research in the field of antibodiestrimeric antibodies and derivatives thereoflaboratory equipment for purifyingdetecting and analysing antibodiestrimeric antibodies and derivatives thereof
Class 10
Medical apparatus and instruments in the nature of medical devices and instruments to purifydetect and analyse antibodiestrimeric antibodies and derivatives thereof from patient samples who have a respiratory conditions; spirometers; medical devices in the nature of medical devices and instruments to purifydetect and analyse antibodiestrimeric antibodies and derivatives thereof from patient samples from body fluid samples; means of administration of medicinal products such as inhalers and nasal spray nebulizers; Medical apparatus and instruments in the nature of syringes for medical purposes; medical devices and instruments to purifydetect and analyse antibodiestrimeric antibodies and derivatives thereof from patient blood samples; diagnostic apparatus for medical use for detection of cancer
Class 42
Medical researchlaboratory research in the field of antibodiestrimeric antibodies and derivatives thereof; product development in the field of medicinesantibodiestrimeric antibodies and derivatives thereof; analysis of antibodiestrimeric antibodies and derivatives thereof in the nature of industrial analysis; contract research services in the field of antibodiestrimeric antibodies and derivatives thereof
Class 44
Medical servicesmedical clinicsmedical assistancepharmacy advice all in the field of antibodiestrimeric antibodies and derivatives thereof; hygienic and beauty care for human beings or animals; veterinary services; agriculturehorticulture and forestry servicescompost spreading; providing information in the field of antibodiestrimeric antibodies and derivatives thereof
Publications
History of USPTO decisions and trademark events.
40 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/05/2022
FIMP
FINAL DISPOSITION PROCESSED
08/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/29/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/12/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/12/2022
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
12/30/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/26/2021
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
12/22/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/21/2021
PUBO
PUBLISHED FOR OPPOSITION
12/21/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/01/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/14/2021
GNRT
NON-FINAL ACTION E-MAILED
04/14/2021
CNRT
NON-FINAL ACTION WRITTEN
04/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/25/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/07/2020
RFNT
REFUSAL PROCESSED BY IB
10/19/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2020
RFRR
REFUSAL PROCESSED BY MPU
09/25/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/03/2020
CNRT
NON-FINAL ACTION WRITTEN
09/02/2020
DOCK
ASSIGNED TO EXAMINER
08/31/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/06/2020
Continuous trademark protection
Get notified about every new filing that threatens TREAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.